FDA Drug Application (204275) for BREO ELLIPTA by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number204275
Product Number001
FormPOWDER;INHALATION
Dosage0.1MG/INH;EQ 0.025MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBREO ELLIPTA
Active IngredientFLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Active IngredientCount
List of drugs with Active Ingredient FLUTICASONE FUROATE3
List of drugs with Active Ingredient VILANTEROL TRIFENATATE2


Back to FDA Applications sponsored by GLAXO GRP LTD